Page last updated: 2024-10-23

aspirin and Clinical Deterioration

aspirin has been researched along with Clinical Deterioration in 1 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Clinical Deterioration: A critical disease progression, often measured by a set of clinical parameters, which activates HOSPITAL RAPID RESPONSE TEAM.

Research Excerpts

ExcerptRelevanceReference
"Among patients admitted with mild to moderate COVID-19 infection, additional treatment with aspirin, atorvastatin, or a combination of the two does not prevent clinical deterioration."5.51Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial). ( Bhatnagar, S; Deepti, S; Dwivedi, T; Ghati, N; Guleria, R; Gupta, R; Kumar, D; Mahendran, M; Mani, K; Mohan, A; Prasad, K; Saxena, A; Thakur, A; Tiwari, P, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ghati, N1
Bhatnagar, S1
Mahendran, M1
Thakur, A1
Prasad, K1
Kumar, D1
Dwivedi, T1
Mani, K1
Tiwari, P1
Gupta, R1
Mohan, A1
Saxena, A1
Guleria, R1
Deepti, S1

Trials

1 trial available for aspirin and Clinical Deterioration

ArticleYear
Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial).
    BMC infectious diseases, 2022, Jul-09, Volume: 22, Issue:1

    Topics: Aspirin; Atorvastatin; Clinical Deterioration; COVID-19 Drug Treatment; Humans; Hydroxymethylglutary

2022